Cargando…

Comparing the Efficacy and Safety of Obeticholic Acid and Semaglutide in Patients With Non-Alcoholic Fatty Liver Disease: A Systematic Review

Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of developing progressive fibrosis, cirrhosis, and hepatocellular carcinoma. As of now, there are no FDA-approved treatments for NAFLD/non-alcoholic steatohepatitis (NASH) or its associated fibrosis. Although many drugs a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Nabeel R, Kulkarni, Vaishnavi Vijaya, Pokhrel, Sushil, Akram, Hamna, Abdelgadir, Arowa, Chatterjee, Abanti, Khan, Safeera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173657/ https://www.ncbi.nlm.nih.gov/pubmed/35693370 http://dx.doi.org/10.7759/cureus.24829

Ejemplares similares

Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review
por: Dick, Maurice H, et al.
Publicado: (2022)

A Better Understanding of Moyamoya in Trisomy 21: A Systematic Review
por: Abdelgadir, Arowa, et al.
Publicado: (2022)

Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
por: Zhu, Kai, et al.
Publicado: (2023)

Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver disease
por: Lee, Seung Min, et al.
Publicado: (2023)

A Systematic Review of the Risk of Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
por: Shahbaz, Mahrukh, et al.
Publicado: (2022)

Safety of Semaglutide
por: Smits, Mark M., et al.
Publicado: (2021)

Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
por: Makri, Evangelia, et al.
Publicado: (2016)

Corrigendum: Safety of Semaglutide
por: Smits, Mark M., et al.
Publicado: (2021)

Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2018)

The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease
por: Zhang, Dan-Ying, et al.
Publicado: (2019)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review
por: Agarwal, Mehak, et al.
Publicado: (2020)

Spectrum of Non-Motor Symptoms in Parkinson's Disease
por: Kumaresan, Maithrayie, et al.
Publicado: (2021)

Efficacy and Safety of Apatinib in the Treatment of Chemotherapy-Refractory Metastatic Colorectal Cancer: A Systematic Review
por: Khan, Aujala Irfan, et al.
Publicado: (2022)

Accuracy of Ultrasonography vs. Elastography in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review
por: Geethakumari, Prabhitha, et al.
Publicado: (2022)

Simultaneous Pancreas-Kidney Transplant: A Positive Stimulus in the Medical World
por: Ali, Muna A, et al.
Publicado: (2020)

Non-alcoholic Fatty Liver Disease and Carbohydrate Restricted Diets: A Case Report and Literature Review
por: Gunaseelan, Luxhman, et al.
Publicado: (2021)

Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study
por: Arai, Taeang, et al.
Publicado: (2022)

Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
por: Quddos, Fatima, et al.
Publicado: (2023)

Comparing the Diagnostic Accuracy of Procalcitonin and C-Reactive Protein in Neonatal Sepsis: A Systematic Review
por: Anugu, NagaSpurthy Reddy, et al.
Publicado: (2021)

A Review on the Efficacy and Safety of Oral Semaglutide
por: Niman, Stephanie, et al.
Publicado: (2021)

Treatment of Nonalcoholic Steatohepatitis by Obeticholic Acid: Current Status
por: Roy, Partho Pratik, et al.
Publicado: (2022)

Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals
por: Ng, Cheng Han, et al.
Publicado: (2023)

Clarification of Obeticholic Acid Dosing: Response to “Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation” by Quigley et al.
por: Feng, Cynthia
Publicado: (2018)

The Effect of Statin Therapy on Inflammatory Biomarkers: A Systematic Review
por: Proute, Matthew C, et al.
Publicado: (2021)

Impact of Change in Lifestyle and Exercise on Cognitive Function in Patients With Rheumatoid Arthritis: A Systematic Review
por: Akram, Aqsa, et al.
Publicado: (2021)

Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
por: Parameswaran, Madhangi, et al.
Publicado: (2021)

Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease
por: Jose, Nijin, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease and Gallstones: A Systematic Review
por: Slouha, Ethan, et al.
Publicado: (2023)

The Effectiveness and Safety of Metformin Compared to Sulfonylureas in Diabetic Nephropathy: A Systematic Review
por: Boddepalli, Chinmayi Sree, et al.
Publicado: (2022)

Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis
por: Nomoto, Hiroshi, et al.
Publicado: (2023)

Probing the Relationship Between the Human Gut Microbiome and Prospects of Prostate Cancer: A Systematic Review
por: Makkena, Vijaya Krishna, et al.
Publicado: (2023)

Anthropometric Measurements and Lifestyle Characteristics of Individuals with Non-alcoholic Fatty Liver Disease
por: Tahir, Faryal, et al.
Publicado: (2020)

Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells
por: New-Aaron, Moses, et al.
Publicado: (2020)

Comparing the Safety and Efficacy of Proton Pump Inhibitors and Histamine-2 Receptor Antagonists in the Management of Patients With Peptic Ulcer Disease: A Systematic Review
por: Begg, Maha, et al.
Publicado: (2023)

Multiple Dyselectrolytemia in a Chronic Alcohol Abuser: A Case Report
por: Meenashi Sundaram, Dakshin, et al.
Publicado: (2023)

Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice
por: Lin, Chuangzhen, et al.
Publicado: (2022)

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice
por: Liu, Szu-Yu, et al.
Publicado: (2022)

How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome
por: Vahora, Ilmaben S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ekta6l07gp8ej95aeg9m2o7d4a